| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income | ||||||
1,911 | 1,160 | 0 | 0 | 0 | ||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||
Interest income retained in Trust Account | ||||||
-6,815 | -5,523 | 0 | 0 | 0 | ||
Changes in operating assets and liabilities: | ||||||
Increase in prepaid expenses | ||||||
-36 | 50 | 0 | 0 | 0 | ||
Increase in accounts payable | ||||||
48 | 46 | 0 | 0 | 0 | ||
Increase in accrued liabilities | ||||||
2,075 | 2,116 | 0 | 0 | 0 | ||
Increase in deferred compensation | ||||||
0 | - | - | - | - | ||
Increase in accrued income and franchise taxes and rounding | ||||||
0 | - | 0 | 0 | 0 | ||
Net cash used in operating activities | ||||||
-2,317 | -2,135 | 0 | 0 | 0 | ||
Cash flows from investing activities: | ||||||
Cash deposited in Trust Account | ||||||
- | 303,152 | 0 | 0 | 0 | ||
Cash flows from financing activities: | ||||||
Proceeds from sale of stock to Anchor Investor | ||||||
- | 3 | 0 | 0 | 0 | ||
Proceeds from Note payable to Sponsor | ||||||
- | 210 | 0 | 0 | 0 | ||
Proceeds from sale of Units to the public | ||||||
- | 300,150 | 0 | 0 | 0 | ||
Proceeds from sale of Private Placement Warrants | ||||||
- | 13,582 | 0 | 0 | 0 | ||
Payment of underwriting discounts | ||||||
- | 7,830 | 0 | 0 | 0 | ||
Payment of offering costs | ||||||
- | 747 | 0 | 0 | 0 | ||
Payment of Note payable to Sponsor | ||||||
- | 300 | 0 | 0 | 0 | ||
Net cash provided by financing activities | ||||||
- | 305,068 | 0 | 0 | 0 | ||
Net increase (decrease) in cash | ||||||
-1,025 | 1,118 | 0 | 0 | 0 | ||
Supplemental disclosure of non-cash financing activities: | ||||||
Deferred underwriters' compensation | ||||||
- | 10,179 | 0 | 0 | 0 | ||
Offering costs included in accounts payable | ||||||
- | - | - | - | 0 | ||